ASO Visual Abstract: Internal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy—Results from the I-SPY2 Clinical Trial
Year: 2024
Type: article
Source: Annals of Surgical Oncology
Authors: Mara A. Piltin, Peter Norwood, Velle Ladores, Rita A. Mukhtar, Candice A. Sauder, Mehra Golshan, Julia Tchou, Roshni Rao, Marie Catherine Lee, Jennifer Son, Chantal Reyna, Kelly Hewitt, Henry Kuerer, Gretchen Ahrendt, Ian Greenwalt, Jennifer Tseng, Lauren Postlewait, Marissa Howard-McNatt, Nora Jaskowiak, Laura J. Esserman, Judy C. Boughey, ISPY2 Locoregional Working Group
Institutions: Mayo Clinic, Quantum Leap Healthcare Collaborative, University of California, San Francisco, University of California Davis Medical Center, UC Davis Comprehensive Cancer Center, Yale University, University of Pennsylvania Health System, University of Pennsylvania, Columbia University Irving Medical Center, Moffitt Cancer Center, MedStar Georgetown University Hospital, Loyola University Medical Center, Loyola Medicine, Vanderbilt University Medical Center, The University of Texas MD Anderson Cancer Center, University of Colorado Health, City of Hope, Emory University, Wake Forest University, University of Chicago
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4401282181
